Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Entyvio (vedolizumab)
i
Other names:
LDP 02, MLN 0002, LDP-02, LPD-02, MLN-0002, MLN-002, MLN-02, MLN02, LDP02, MLN0002, LPD 02, LPD02, MLN 002, MLN002, MLN 02
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Takeda
Drug class:
α4β7 integrin antagonist
Related drugs:
‹
natalizumab (0)
natalizumab (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.